HK, Nasdaq-listed Chinese Biotech Firm BeiGene To Raise $2.08b In Share Sale

Business - Published date: Monday July 13, 2020.

Chinese commercial-stage, oncology-focused biotech firm BeiGene on Monday announced that it is raising gross proceeds o... Read more